Bringing the fundamentals into focus…
Back to Bio-Rad Laboratories, Inc.
How Bio-Rad Laboratories, Inc. stacks up
BIO · against 160 other Healthcare companies of similar size
Overall
43/ 100
Near the bottom of its peers.
Ranked #126 of 161 · scores higher than 21% of peers
Bars: peers in each 10-point band of the overall score19 peers with an overall score of 40–49, including BIO · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around BIO| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 2 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 3 | 10.7B USD | 78 | 77 | 85 | 84 | 0 / 2 | |
| 3 | 9.0B USD | 78 | 50 | 80 | 94 | 0 / 2 | |
| 3 | 6.3B USD | 78 | 50 | 90 | 86 | 0 / 2 | |
| 122 | 64.1B CNY (≈$9.0B) | 45 | 56 | 13 | 60 | 1 / 2 | |
| 122 | 13.7B USD | 45 | 8 | 79 | 22 | 0 / 2 | |
| 122 | 6.6B USD | 45 | 8 | — | 26 | 0 / 2 | |
| 125 | 6.2B USD | 44 | 8 | 82 | 10 | 0 / 2 | |
| 126 | 10.0B USD | 43 | 52 | 25 | 50 | 1 / 2 | |
| 126 | 7.2B USD | 43 | 48 | 57 | 40 | 2 / 2 | |
| 126 | 5.5B USD | 43 | 53 | 24 | 76 | 2 / 2 | |
| 129 | 10.8B USD | 41 | 41 | 37 | 41 | 1 / 2 | |
| 130 | 18.2B USD | 40 | 48 | 29 | 56 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score